Insiders Updates
Analysts review Akebia Therapeutics Inc.’s rating
Akebia Therapeutics Inc.’s recent filing unveils that its CEO and President Butler John P. unloaded Company’s shares for reported $73581.0
Menu
Akebia Therapeutics Inc.’s recent filing unveils that its CEO and President Butler John P. unloaded Company’s shares for reported $73581.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Akebia Therapeutics Inc. revealed its CEO and President Butler John P. unloaded Company’s shares for reported $73581.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Akebia Therapeutics Inc.’s recent filing unveils that its CEO and President Butler John P. unloaded Company’s shares for reported $73581.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Akebia Therapeutics
Akebia Therapeutics Inc.’s recent filing unveils that its CEO and President Butler John P. unloaded Company’s shares for reported $73581.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Akebia Therapeutics
In a filing, Akebia Therapeutics Inc. revealed its CEO and President Butler John P. unloaded Company’s shares for reported $73581.0